Interferon-beta treatment in patients with childhood-onset multiple sclerosis.
We present a report of the use of interferon-beta before 18 years of age in 16 patients with childhood-onset multiple sclerosis. This study demonstrated that the treatment is safe and well tolerated.
Mikaeloff
Y
Y
Department of Neuropediatrics, Saint-Vincent de Paul Hospital, Paris, France.
Moreau
T
T
Debouverie
M
M
Pelletier
J
J
Lebrun
C
C
Gout
O
O
Pedespan
J M
JM
Van Hulle
C
C
Vermersch
P
P
Ponsot
G
G
D000276:Adjuvants, Immunologic / Q000009:adverse effects / Q000627:therapeutic use*; D000293:Adolescent; D002648:Child; D005260:Female; D006801:Humans; D016899:Interferon-beta / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D009103:Multiple Sclerosis / Q000188:drug therapy*; D016896:Treatment Outcome
D000276:Adjuvants, Immunologic; D016899:Interferon-beta